TTD Drug ID: DAP000974

Drug Information
Name	Phenylbutazone
Synonyms	KBio2_004127; Alqoverin; Artrizone; Fenibutazona; SPECTRUM1500482; Scanbutazone; Ipsoflame; MolPort-001-783-564; Novophenyl; AZOLID (TN); Butaphen; Fenylbutazon; Buvetzone; Bute, Butazolidin, Butatron, Phenylbutazone; Butylpyrin; Buzon; esteve; Fenibutal; DivK1c_000331; Robizone; component of Azolid-A; Zolidinum; HMS2091P08; Butartril; B.T.Z; Diozol; CHEBI:48574; G 13871; Rectofasa; NCGC00015846-01; Bunetzone; Phenyl-Mobuzon; 3,5-Dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin; NCGC00023855-05; fe nilbutine; Butartrina; Phenyzone; Lopac-P-8386; art rizin; Tetnor; Fenartil; 4-Butyl-1,2-diphenyl-3,5-pyrazolidinedione; Butadiona; NCI-C55414; HMS1920H06; Chembutazone; Butone; Intrabutazone; 1,2-Diphenyl-4-butyl-3,5-dioxopyrazolidine; NCGC00015846-06; Fenibutasan; Lopac0_000993; 1,2-Diphenyl-2,3-dioxo-4-N-butylpyrazoline; KBioSS_001559; Antadol; Reumuzol; D010653; EINECS 200-029-0; Butagesic; NCGC00023855-04; R-3-ZON; D00510; 1,2-Diphenyl-3,5-dioxo-4-butylpyrazolidine; Malgesic; Azolid; CCRIS 2374; Rubatone; CHEMBL101; Reumune; C07440; P8386_SIGMA; 3,5-dioxo-4-butyl-1-diphenyl-pyrazolidine; Usaf ge-15; Fenibutol; HSDB 3159; Alka Butazolidin; Lingel; Phen-Buta-Vet; 50-33-9; Intrazone; NSC25134; Schemergen; Butaluy; Schemergin; WLN: T5VNNV EHJ BR& CR& E4; 4297-92-1; Azobutyl; Fenilbutina; Reumazol; Reumasyl; 'Esteve'; Febuzina; Robizon-V; Oprea1_416494; Fenilbutazone; DB08343; Butatron; 4-Butyl-1,2 -diphenyl-3,5-dioxo pyrazolidine; Butacote; KBioGR_000954; MLS001148412; Azdid; Alindor; Buta phen; Benzone; Spectrum4_000477; B.t.z.; NCGC00015846-12; Pyrabutol; Mephabutazon; 4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione; VAC-10; MLS000069424; Tencodyne; UNII-GN5P7K3T8S; SMR000059073; Reumazin; Uzone; Bio-0693; KBio3_001589; NCGC00023855-07; MLS002152929; Butapyrazole; Bute; butyl pyrin; Apo-Phenylbutazone; Butalgina; P1686; Todalgil; Fenilbutazona [INN-Spanish]; butadione; Phenbutazol; P 8386; Artizin; Phenylbutazon; Ticinil; Butidiona; Flexazone; Phenopyrine; Zolaphen; Reudo; Bizolin; Spectrum5_001335; Mepha-Butazon; S1654_Selleck; 3,5-Dioxo-1,2-diphenyl-4-N-butylpyrazolidine; Phebuzin; Spectrum_001079; Butazolidine; Ia-But; Fenilbutazone [DCIT]; Tevcodyne; IDI1_000331; Fenotone; AC-683; Phenylbutazonum [INN-Latin]; Busone; STK388348; Phebuzine; Elmedal; SR-01000000004-4; Ecobutazone; KBio2_006695; Intalbut; NINDS_000331; NCGC00023855-06; SPBio_001283; 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-; AC1L1IXW; Robizone-V; Bizolin 200; Digibutina; Butapirazol; 1,2-diphenyl-3,5-dioxo-4-n-butylpyrazoline; Butazina; Fenilidina; 4-Butyl-1,2-diphenylpyrazolidine-3,5-dione; Butazolidin; Arthrizon; Butadion; Equi bute; HMS2090H17; 4-Butyl-1,2-diphenyl-3,5-dioxo pyrazolidine; Shigrodin; BSPBio_002369; Reudox; Phenylbutazone [USAN:INN:BAN:JAN]; UNM000001255503; LS-71; Pyrazolidin; Therazone; Kadol; nchembio.128-comp31; Anerval; Praecirheumin; Butacompren; Tazone; Butarecbon; Diphenylbutazone; Butoz; Alkabutazona; 4-Butyl-1,2-diphenyl-3,5-dioxopyrazolidine; Neo-zoline; NCGC00023855-03; Merizone; Phenbutazone; Phenylbutazon [German]; AC1Q2VLE; KBio1_000331; NSC 25134; CID4781; 3,5-Dioxe-4 buty-1, diphenyl-pyrazolidine; Fenilbutazona; Fenilbutazon; Nadozone; Phenyl butazone; Phenyzene; HMS501A13; Equipalazone; Phenylbutaz; AKOS001592731; NCI-C56531; NCGC00015846-02; Reupolar; Anpuzone; 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE; Artropan; NCGC00181112-01; Wescozone; Butiwas-Simple; BRN 0290080; phenylbutazone; DB00812; DA-192; A 7514; Diphebuzol; G 13,871; Spectrum2_001282; NCGC00023855-08; Artrizin; Butadionum; Equiphen; I01-0883; Fenilbutine; Butazona; Phenylbutazonum; Butalidon; EU-0100993; Phenylbutazone (JP15/USP/INN); Betazed; Cotylbutazone; Butapirazole; Spectrum3_000675; Nadazone; P1Z; KBio2_001559; Anuspiramin; Pirarreumol "B"; Eributazone; Exrheudon N; Diossidone; Mephabutazone; 1,2-Diphenyl-4-butyl-3,5-pyrazolidinedione; Pirarreumol B
Indication	Chronic pain			Approved    [1]
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
Therapeutic Class	Analgesics
CAS Number	CAS 50-33-9
Formular	C19H20N2O2
PubChem Compound ID	CID 4781.
PubChem Substance ID	SID 9644.
SuperDrug ATC ID	M01AA01;
SuperDrug CAS ID	000050339;
Target	COX-2			Inhibitor	[2]
Ref 1	Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opin Emerg Drugs. 2007 May;12(2):229-52. To Reference
Ref 2	COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis. Pharmacol Res. 2005 Oct;52(4):302-6. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.